May 5, 2020 / 11:15 AM / in 24 days

BRIEF-Akebia Announces Positive Top-Line Results From Global Phase 3 Program Of Vadadustat

May 5 (Reuters) - Akebia Therapeutics Inc:

* AKEBIA THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE RESULTS FROM GLOBAL PHASE 3 PROGRAM OF VADADUSTAT FOR TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE IN ADULT PATIENTS ON DIALYSIS

* AKEBIA THERAPEUTICS INC - VADADUSTAT ACHIEVED PRIMARY EFFICACY AND CARDIOVASCULAR SAFETY ENDPOINTS

* AKEBIA THERAPEUTICS INC - VADADUSTAT ALSO ACHIEVED PRIMARY SAFETY ENDPOINT OF INNO(2)VATE PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below